Please login to the form below

Indians scalp cowboys in patent war

An unlikely treaty between global pharma and native Americans
In the United States, the drug company Allergan has found an ingenious solution to the patent expiry issue. It involves an unlikely alliance with a native American tribe.  
To defend its dry eye treatment Restasis (ciclosporin) against generic competition, Allergan has transferred the patent to the St Regis Mohawks, who have 'sovereign immunity' under US law. The result is a win-win outcome, as the Mohawks gain over $13m a year in royalties, while Allergan protects its annual sales of the drug, which was worth $1.5 billion last year. The only losers are the generics companies.  
This is a rare case of indians winning against cowboys, if that is how you view generic manufacturers.  
In America, tribal reservations are often dispiriting places, with high levels of unemployment, and health problems including alcoholism and drug addiction. Many reservations take advantage of US tax laws to set up gambling casinos as a revenue stream for otherwise impoverished tribes.  
The idea of using sovereign immunity was broached to the Mohawks by a Dallas law firm with the wonderful name of Shore Chan DePumpo. The ruling is powerful medicine for native Americans who have faced years of exploitation and underprivilege. So even if you regard generics companies as champions of affordable healthcare, it's hard to argue against the poetic justice of the decision.  
The Restasis case is not so much an example of 'evergreening' - extending the patent life of a compound by devising slightly different formulations - as a 'patent relay', passing the baton to keep it beyond the reach of competitors.  
The case may open up lots of creative ways for innovative pharmaceutical companies to protect their intellectual property. What is to stop them transferring patents to other deserving entities? Why not assign copyright to threatened animal species such as elephants or rhinos (or the charities that look after them), which could benefit from the income but are protected against legal claims?  
You can expect lawyers working for generics manufacturers to vigorously challenge the Allergan strategy. At the same time, imaginative patent lawyers will be racking their brains to exploit new opportunities.  
In the meantime, the St Regis Mohawks can safely say: you may steal our land and our buffalo, but you won't steal our ciclosporin ophthalmic emulsion. And there are 500 more tribes who could benefit from similar arrangements.

© 2017 Life Healthcare Communications

27th September 2017



Company Details

Life Healthcare Communications

+44 (0)1344 899050

Contact Website

Life Healthcare Communications
The Hernes Oak
North Street

Latest content on this profile

Barber shops provide a short cut to BP reduction
As well as a haircut, barbers can shave millimetres off men's blood pressure
Life Healthcare Communications
To track disease, follow the money
Using paper currency to track infections sounds like a clever idea. But we think the smart money is on your phone.
Life Healthcare Communications
‘Tis the season to be judgmental…
Fa-la-la-la-la, la-la-la-la Yes, it’s that time of year again when adverts from well-known department stores make the news. Countless news articles are given over to which of this year’s creative offerings made the best Christmas ad.
Life Healthcare Communications
Social Media and Health: the Cure or the Disease?
Social media is going through a crisis. So is this the right time for the pharma industry to join the conversation?
Life Healthcare Communications
Hunt vs Hawking: We'll call it a draw
Who won the recent bout between Jeremy Hunt and Stephen Hawking? We'll let you score the cards.
Life Healthcare Communications
Indians scalp cowboys in patent war
An unlikely treaty between global pharma and native Americans
Life Healthcare Communications